AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma
Background & Aims Hepatocellular carcinoma (HCC), the most common primary liver cancer,
remains a deadly cancer, with an incidence that has tripled in the United States since 1980…
remains a deadly cancer, with an incidence that has tripled in the United States since 1980…
Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases
…, K Hashimoto, M Fujiki, C Quintini, BN Estfan… - JAMA …, 2022 - jamanetwork.com
Importance Colorectal cancer is a leading cause of cancer-related death, and nearly 70% of
patients with this cancer have unresectable colorectal cancer liver metastases (CRLMs). …
patients with this cancer have unresectable colorectal cancer liver metastases (CRLMs). …
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy
Background: Advanced hepatocellular cancer (HCC) is an incurable disease with limited
options for systemic treatment. Sorafenib was approved for advanced HCC based on trials in …
options for systemic treatment. Sorafenib was approved for advanced HCC based on trials in …
Epidemiology of cholangiocarcinoma; United States incidence and mortality trends
…, CR Simons-Linares, MB Sonbol, BN Estfan - Clinics and research in …, 2020 - Elsevier
Background Cholangiocarcinoma is an aggressive malignancy with few available studies
assessing incidence and mortality. In this study, we aim to investigate trends of incidence and …
assessing incidence and mortality. In this study, we aim to investigate trends of incidence and …
[HTML][HTML] Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors
…, N Benanni-Baiti, K Hauser, S Ayvaz, B Estfan - PLoS …, 2018 - journals.plos.org
Introduction Prognostication in cancer is challenging and inaccurate. C-Reactive Protein (CRP),
a cheap and sensitive marker of inflammation may help. This study investigated the …
a cheap and sensitive marker of inflammation may help. This study investigated the …
Prospective clinical study of precision oncology in solid tumors
…, JP Stevenson, R Pelley, B Estfan… - Journal of the …, 2016 - academic.oup.com
Systematic studies evaluating clinical benefit of tumor genomic profiling are lacking. We
conducted a prospective study in 250 patients with select solid tumors at the Cleveland Clinic. …
conducted a prospective study in 250 patients with select solid tumors at the Cleveland Clinic. …
[PDF][PDF] Symptom management: an important part of cancer care
LK Do Shoemaker, B Estfan, R Induru… - Cleveland Clinic journal …, 2011 - gfcourse.co.il
. ABSTRACT Physicians can do a better job of palliating symptoms and improving the quality
of life of cancer patients if they understand the principles of symptom management. We …
of life of cancer patients if they understand the principles of symptom management. We …
[HTML][HTML] Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer
…, G Dubyak, RT Lee, B Estfan… - The Journal of …, 2024 - Am Soc Clin Investig
Neutrophil extracellular traps (NETs), a web-like structure of cytosolic and granule proteins
assembled on decondensed chromatin, kill pathogens and cause tissue damage in diseases. …
assembled on decondensed chromatin, kill pathogens and cause tissue damage in diseases. …
Components of the anorexia–cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia
…, S LeGrand, R Lagman, L Bicanovsky, B Estfan… - Supportive care in …, 2009 - Springer
Introduction Cancer-related anorexia is traditionally considered part of a complex but ill-defined
anorexia–cachexia syndrome in which anorexia is intimately associated with other …
anorexia–cachexia syndrome in which anorexia is intimately associated with other …
[HTML][HTML] Errors in opioid prescribing: a prospective survey in cancer pain
PE Shaheen, SB LeGrand, D Walsh, B Estfan… - Journal of pain and …, 2010 - Elsevier
CONTEXT: Cancer pain is debilitating and has multidimensional consequences. It can be
treated adequately in up to 90% of patients by following pain management guidelines. …
treated adequately in up to 90% of patients by following pain management guidelines. …